Prof Joost de Bruijn
BSc, PhD, FBSE
Visiting Professor of Biomaterials
E407, Engineering, Mile End
|Expertise:||Hard tissue replacement, bone tissue engineering, regenerative medicine, synthetic osteoinductive materials, bioreactor systems for adult stem cell expansion|
|Affiliations:||Fellow of Biomaterials Science and Engineering|
Joost de Bruijn, PhD, FBSE is a serial entrepreneur with more than 25yrs experience in academia and industry. Joost is Chief Executive Officer of Kuros Biosciences AG (SIX: KURN) since 2017 and has completed several successful business deals and raised over $50m in equity financing in the past 3 years. As serial entrepreneur, Joost founded Xpand Biotechnology BV in 2014 (acquired by Kuros Biosciences AG in 2017), Progentix Orthobiology BV (sold to NuVasive Inc. in 2018) and Scinus Cell Expansion BV. Since 2004, Dr. de Bruijn holds the position of Visiting Professor of Biomaterials at Queen Mary University of London, UK and was Professor of Regenerative Medicine and Entrepreneurship at Twente University, NL from 2011-2019. Dr. de Bruijn has more than 28 years' experience in academia and the life science industry and has brought several technologies to the clinic. He is author on 185 peer-reviewed publications and inventor of 35 patents and patent families. Dr. de Bruijn is scientific editor of the world's first open-access journal, European Cells and Materials, and reviewer for numerous international biomaterials, tissue engineering and regenerative medicine journals. He received his PhD Cum Laude from Leiden University in 1993 and is a citizen of The Netherlands.